- Home
- INBX vs PRGS Comparison
INBX vs PRGS Comparison
Compare INBX & PRGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INBX | PRGS |
|---|---|---|
| Founded | 2010 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 2024 | 1995 |
Fundamental Metrics
Financial Performance| Metric | INBX | PRGS |
|---|---|---|
| Price | $103.63 | $44.36 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $150.00 | $49.50 |
| AVG Volume (30 Days) | 196.7K | ★ 457.3K |
| Earning Date | 05-15-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 7.79 |
| EPS | N/A | ★ 1.03 |
| Revenue | $1,300,000.00 | ★ $397,572,000.00 |
| Revenue This Year | N/A | $3.70 |
| Revenue Next Year | N/A | $1.08 |
| P/E Ratio | ★ N/A | $41.95 |
| Revenue Growth | ★ 550.00 | N/A |
| 52 Week Low | $26.19 | $23.82 |
| 52 Week High | $155.29 | $47.37 |
Technical Indicators
Market Signals| Indicator | INBX | PRGS |
|---|---|---|
| Relative Strength Index (RSI) | 62.37 | 63.47 |
| Support Level | $99.20 | $39.05 |
| Resistance Level | $106.40 | $45.49 |
| Average True Range (ATR) | 6.20 | 1.35 |
| MACD | 1.75 | -0.14 |
| Stochastic Oscillator | 86.65 | 83.35 |
Price Performance
Historical ComparisonAbout INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About PRGS Progress Software Corporation (DE)
Progress Software Corp provides software products that enable customers to develop, deploy, and manage AI-powered applications and digital experiences. The Company operates across North America, Latin America, Europe, the Middle East and Africa (EMEA), and Asia Pacific through subsidiaries and distributors, generating a majority of its revenue from the United States. Its product portfolio includes Progress Agentic RAG, Automate MFT, Chef, Corticon, DataDirect, Developer Tools, Flowmon, Kemp LoadMaster, MarkLogic, MOVEit, OpenEdge, Semaphore, ShareFile, Sitefinity, and WhatsUp Gold, offering solutions for application development, data connectivity, DevOps automation, managed file transfer, network security, and digital experience. It generates maximum revenue from the United States.